−£50k
1 period on recordActive15455652Private limited companyThornbury
LAYADE PHARMA LTD
E31/10001
Summary
LAYADE PHARMA LTD is an active private limited company (company number 15455652) incorporated on 31 January 2024, registered in Thornbury. Its registered activity is wholesale of pharmaceutical goods (SIC 46460). Latest micro accounts cover the period ending 31 January 2025, showing net assets of −£50k, with 5 employees on average. As micro-entity accounts, no profit and loss account is filed, so turnover and profit are not public.
Peer position · net assets
By net assets it sits in the bottom quarter of 1,797 comparable companies in the UK (median £3,718, upper quartile £148k).
02
Key dates
- Incorporated
- 31 January 20242 yrs ago
- Next accounts due
- 31 October 2026in 9 days
- Confirmation statement due
- 14 February 2027in 115 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
03
Activity
- SIC 46460
- Wholesale of pharmaceutical goods
- SIC 47730
- Dispensing chemist in specialised stores
- SIC 86900
- Other human health activities
- Accounts type
- Micro Entity
- Size band
- MicroCompanies Act thresholds
04
Financials
Not reported
Not disclosed
5
1 period on record| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 January 2025 | −£50k | — | — | £171k | — | — | 5 |
Current ratio0.65Current liabilities exceed current assets
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing; micro-entity accounts contain no profit and loss account.
05
Firmoscan score
31 / 100 · grade E
| 50 | Starting scoreEvery scored company starts here |
| −15 | Negative net assetsNet assets £-49,671 at 2025-01-31 |
| −8 | Current liabilities exceed current assetsCurrent ratio 0.65 |
| +4 | Past first filingsIncorporated 2024-01-31 |
| 31 | Score, grade E |
A transparent, rules-based score from filed data only: every point lists its evidence. It is not a credit rating or advice. How the score is computed.
06
Ownership and control
- Mr Adedamola Layade
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents.
07
Timeline
- Confirmation statement duein 115 days
- Next accounts duein 9 days
- Accounts period endNet liabilities £50k · micro accounts
- Incorporated
08
Similar companies in Bristol
- GREAT FRAMES LTDYeovil · inc. Oct 2023
- EVOLUTION XET LTDBristol · inc. Oct 2023
- ZYDUS PHARMACEUTICALS UK LTDBristol · inc. Feb 2023
- LAYANSON PHARMA LTDThornbury · inc. Feb 2023
- LAYANSON2 PHARMA LTDThornbury · inc. Mar 2025
- CURA PHARMA SERVICES LTDWestbury · inc. Nov 2022
All companies incorporated on 31 January 2024 · in Jan 2024.
09
Reminders for LAYADE PHARMA LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.